Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €56.56 EUR
Change Today -2.04 / -3.48%
Volume 3.2K
As of 3:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Pension Plan for astrazeneca plc (ZEG)

Shares for Stock Options
-- Million
Common Shares for Exercise
For the fiscal year 2014 in U.S. Dollars
Projected Benefit Obligation136.00
Accumulative Benefit Obligation532.00
Total Pension Assets10,240.00
Def. Benefit Service Cost136.00
Def. Benefit Plan Interest Cost532.00
Def. Benefit Plan Return On Assets-440.00
Def. Benefit Plan Other Cost94.00
Def. Benefit Plan Total Cost302.00
Def. Contribution Plan Cost238.00
Total Pension Expense540.00
Exp. Ret. on Pension Assets--
Discount Rate on Obligation3.50
Assumed Comp. Growth Rate--
Other Post-Retire Benefits Exp.20.00
Other Benefits Obligation402.00

Stock Options for astrazeneca plc (ZEG)

Outstanding at Beginning of Year--
Issued During the Year--
Exercised During the Year6.00
Canceled During the Year--
Outstanding at the End of Year--
W/Avg. Exercise Price of Options Granted--
W/Avg. Exercise Price of Options Outstanding--

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZEG:GR €56.56 EUR -2.04

ZEG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $139.84 USD -1.90
Abbott Laboratories $43.07 USD -1.07
Biogen Inc $302.26 USD +0.63
Eli Lilly & Co $80.32 USD -1.28
Valeant Pharmaceuticals International Inc C$304.44 CAD +3.19
View Industry Companies

Industry Analysis


Industry Average

Valuation ZEG Industry Range
Price/Earnings 67.5x
Price/Sales 3.2x
Price/Book 4.4x
Price/Cash Flow 67.5x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at